Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

Grade Last Price % Change Price Change
F 3.07 2.33% 0.07
NLSP closed down 9.91 percent on Tuesday, February 23, 2021, on 64 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical NLSP trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 4.33%
Doji - Bullish? Reversal 4.33%
Gapped Down Weakness 4.33%
NR7 Range Contraction -6.01%
Inside Day Range Contraction -6.01%
Calm After Storm Range Contraction -5.44%
Hot IPO Pullback Bullish Swing Setup 0.97%
Down 3 Days in a Row Weakness 0.97%
Down 4 Days in a Row Weakness 0.97%
Hot IPO Pullback Bullish Swing Setup -3.69%
Older End-of-Day Signals for NLSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 2 hours ago
Up 5% about 2 hours ago
Down 1% about 2 hours ago
Up 3% about 2 hours ago
Up 2% about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Sleep Disorders Attention Deficit Hyperactivity Disorder Amphetamine Drug Therapies Narcolepsy Adhd Methylphenidate Cataplexy Childhood Psychiatric Disorders

Is NLSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.0
52 Week Low 2.35
Average Volume 413,775
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 3.25
Average True Range 0.50
ADX 0.0
+DI 19.21
-DI 18.11
Chandelier Exit (Long, 3 ATRs ) 2.51
Chandelier Exit (Short, 3 ATRs ) 3.84
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.03
MACD Signal Line 0.02
MACD Histogram 0.0025
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.86
Resistance 3 (R3) 3.86 3.57 3.71
Resistance 2 (R2) 3.57 3.36 3.57 3.66
Resistance 1 (R1) 3.29 3.22 3.29 3.29 3.62
Pivot Point 3.00 3.00 3.00 3.00 3.00
Support 1 (S1) 2.72 2.79 2.72 2.72 2.38
Support 2 (S2) 2.43 2.65 2.43 2.34
Support 3 (S3) 2.15 2.43 2.29
Support 4 (S4) 2.15